KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Procter & Gamble (PG) EBITDA (2016 - 2025)

Historic EBITDA for Procter & Gamble (PG) over the last 17 years, with Q4 2025 value amounting to $5.4 billion.

  • Procter & Gamble's EBITDA fell 653.2% to $5.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $20.1 billion, marking a year-over-year increase of 126.74%. This contributed to the annual value of $20.5 billion for FY2025, which is 1027.77% up from last year.
  • Procter & Gamble's EBITDA amounted to $5.4 billion in Q4 2025, which was down 653.2% from $5.9 billion recorded in Q3 2025.
  • Procter & Gamble's 5-year EBITDA high stood at $5.9 billion for Q3 2025, and its period low was $3.5 billion during Q2 2021.
  • For the 5-year period, Procter & Gamble's EBITDA averaged around $4.7 billion, with its median value being $4.5 billion (2024).
  • As far as peak fluctuations go, Procter & Gamble's EBITDA plummeted by 741.1% in 2022, and later surged by 2950.6% in 2024.
  • Procter & Gamble's EBITDA (Quarter) stood at $5.2 billion in 2021, then dropped by 7.41% to $4.8 billion in 2022, then fell by 7.36% to $4.4 billion in 2023, then increased by 29.51% to $5.7 billion in 2024, then dropped by 6.53% to $5.4 billion in 2025.
  • Its EBITDA stands at $5.4 billion for Q4 2025, versus $5.9 billion for Q3 2025 and $4.4 billion for Q2 2025.